9th Microbiome Movement Drug Development Summit

July 10 - 12, 2024 - MA US

Hanson Wade

info@hansonwade.com
Phone:+1 617 455 4188

As landmark Ferring and Seres Therapeutics approvals prove the safety of the microbiome modality, robust clinical efficacy data for disease beyond infectious is now paramount to reinvigorate investment across the community. The 9th Microbiome Movement Drug Development Summit returns as the industry's trusted, definitive forum for the global network of microbial therapeutic developers. It ensures teams can stay ahead of the curve to robustly prove clinical efficacy as regulator and investor scrutiny necessitates more compelling data than ever before. Your only meeting dedicated to supporting business-critical networking, featuring a start-up showcase to connect the ecosystem, this is an unmissable touchpoint for developers to gain insights from pipelines generating robust data in the clinic and improve your navigation of a fast-evolving market landscape. Across 2 conference days, with Translational, Clinical and Manufacturing tracks, and an additional 4 deep-dive workshops and a Focus Day designed for innovation scouting and networking, join C-Level and Investor stakeholders, as 250+ innovators and thought-leaders gather under the common goal to prove the power of microbiome modalities! Be part of the industry's premier platform for connection-building in 2024 and shape the future direction of the microbiome-altering therapeutics field! Time: 8:30 AM - 4:15 PM

More Information